Publications by authors named "Alimu Dayimu"

Claim this Profile
A
A Trial of Semicircular Canal Plugging vs. Intratympanic Gentamicin for Menière's Disease.
Daogong Zhang, Xiaofei Li, Raymond Van de Berg, Yafeng Lyu, Alimu Dayimu

Laryngoscope· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.
Joanna A Krupka, Ilias Moutsopoulos, Natasha H Cutmore, Christopher S Trethewey, Alimu Dayimu

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying modifiable factors and their joint associations on late-onset schizophrenia risk in the UK Biobank: a prospective exposure-wide association study.
Fan Jiang, Qiuyue Dong, Emilio Fernandez-Egea, Rudolf N Cardinal, Xinyu Li, Alimu Dayimu

BMJ Ment Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seamless monotherapy-combination phase I dose-escalation model-based design.
Libby Daniells, Thomas Jaki, Alimu Dayimu, Nikos Demiris, Basu Bristi

Clin Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoreceptor Layer Thinning as Biomarker for Circulatory Premature Mortality: UK Biobank Cohort Study.
Mayinuer Yusufu, Mengtian Kang, Alimu Dayimu, Danli Shi, Lisa Zhuoting Zhu

Transl Vis Sci Technol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.
Harveer Dev, Mark Linch, Krishna Narahari, Toby Milne-Clark, Melissa Cheung, Alimu Dayimu

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.
Jean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, Karen Pinilla Alba, Alimu Dayimu

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization study.
Fan Jiang, Qiuyue Dong, Sijia Wu, Xinhui Liu, Alimu Dayimu

BMC Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol.
Katie Andresen, Emma Cutting, Dimitrios Apostolopoulos, Amy H Evans, Laura Oakley, Alimu Dayimu

BMJ Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample size determination for prediction models via learning-type curves.
Alimu Dayimu, Nikola Simidjievski, Nikolaos Demiris, Jean Abraham

Stat Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Jean E Abraham, Karen Pinilla, Alimu Dayimu, Louise Grybowicz, Nikolaos Demiris

Nature· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global evolving patterns and cross-country inequalities of inflammatory bowel disease burden from 1990 to 2019: a worldwide report.
Lina Cao, Alimu Dayimu, Xiao Guan, Miao Duan, Shuyan Zeng

Inflamm Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF mutant advanced melanoma (INTERIM).
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, Jenny Nobes, Ruth Board

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal Vascular Measurements and Mortality Risk: Evidence From the UK Biobank Study.
Mayinuer Yusufu, Yutong Chen, Alimu Dayimu, Gabriella Bulloch, Shanshan Jin

Transl Vis Sci Technol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.
Ishan Mehta, Alimu Dayimu, Satish Kumar, Clare Boobier, Olabode Oladipo

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma.
Alimu Dayimu, Lorena Di Lisio, Shubha Anand, Isart Roca-Carreras, Wendi Qian

Br J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report.
Colin Watts, Alimu Dayimu, Tomasz Matys, Keyoumars Ashkan, Stephen Price

J Pers Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term functional outcomes of hearing and speech rehabilitation efficacy among paediatric cochlear implant recipients in Shandong, China.
Fan Jiang, Dayimu Alimu, Wen-Zhe Qin, Hannah Kupper

Disabil Rehabil· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.
Yuan Lu, Quanping Su, Ming Li, Alimu Dayimu, Xiaoyu Dai

Biomed Res Int· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of Lipids Profile and Incident Cardiovascular Disease Risk: A Longitudinal Cohort Study.
Alimu Dayimu, Chunxia Wang, Jiangbing Li, Bingbing Fan, Xiaokang Ji

J Am Heart Assoc· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of Haemoglobin and incident stroke risk: a longitudinal cohort study.
Alimu Dayimu, Wendi Qian, Bingbing Fan, Chunxia Wang, Jiangbing Li

BMC Public Health· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-area spatial statistical analysis of malaria clusters and hotspots in Cameroon;2000-2015.
Marlvin Anemey Tewara, Prisca Ngetemalah Mbah-Fongkimeh, Alimu Dayimu, Fengling Kang, Fuzhong Xue

BMC Infect Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Association between hematocrit and risk of incident hypertension: a cohort study].
Y F Chen, C X Wang, Z S Yuan, W C Zhang, Y F Liu, Alimu Dayimu

Zhonghua Xin Xue Guan Bing Za Zhi· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis